Physician profile
Ejaz Khan
NPI 1669416160
$19,950.95
in general payments reported to CMS, 2019-2025
41 companies · $1,673 in 2025
The $1,673 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $373 · 2021: $1,093 · 2022: $2,188 · 2023: $1,600 · 2024: $2,242 · 2025: $1,673.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,772 · Travel and Lodging: $678 · Education: $64.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,772.06 |
| Travel and Lodging | $677.88 |
| Education | $64.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $10,615.36 | 2019-2025 | Carto 3, Nuvision Ice Catheter |
| Boston Scientific Corporation | $2,946.73 | 2019-2025 | Watchman Access System, Lux-Dx Insertable Cardiac Monitor, Fineline II Sterox |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $705.12 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $565.54 | 2021-2025 | Farxiga, Lokelma, Brilinta |
| Philips North America LLC | $543.67 | 2021-2025 | (5044) Mcot, Mcot, (5050) Extended Holter |
| E.R. Squibb & Sons, L.L.C. | $518.03 | 2020-2025 | Camzyos, Eliquis |
| Medtronic, INC. | $479.52 | 2021-2024 | Micra, Na, Ffrangio |
| Novartis Pharmaceuticals Corporation | $393.84 | 2019-2025 | |
| Atricure, INC. | $382.08 | 2019-2025 | Atriclip Laa Exclusion System, Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax |
| Novo Nordisk INC | $344.40 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Abbott Laboratories | $340.32 | 2019-2024 | Amplatzer Amulet |
| Amgen INC. | $253.30 | 2019-2024 | Repatha |
| Janssen Pharmaceuticals, INC | $197.39 | 2019-2022 | |
| Pfizer INC. | $194.28 | 2024-2025 | |
| Baxter Healthcare | $177.30 | 2024-2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $131.13 | 2021 | |
| Amarin Pharma, INC. | $128.74 | 2019 | |
| Alnylam Pharmaceuticals INC. | $117.47 | 2024-2025 | Amvuttra, Onpattro |
| Scpharmaceuticals INC. | $108.40 | 2024-2025 | |
| Cardiva Medical, INC. | $82.20 | 2023-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Sanofi-Aventis U.S. LLC | $67.92 | 2019-2024 | |
| Medtronic Vascular, INC. | $63.95 | 2019 | |
| Heartflow, INC. | $61.45 | 2023-2025 | Ffrct |
| Exact Sciences Corporation | $59.19 | 2024 | Cologuard Collection Kit |
| Lilly USA, LLC | $51.85 | 2025 | Zepbound |
| Impulse Dynamics (USA) INC. | $39.46 | 2024 | Optimizer |
| Cvrx, INC. | $37.77 | 2025 | Barostim Neo System |
| Kestra Medical Technology Services, INC. | $36.97 | 2024-2025 | Assure Wcd |
| Cleerly, INC. | $35.12 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Abiomed | $33.65 | 2024 | Impella |
| Janssen Biotech, INC. | $33.02 | 2025 | Tremfya |
| Penumbra, INC. | $30.80 | 2025 | Indigo System |
| Medicomp INC | $27.54 | 2019 | |
| Recor Medical INC | $26.20 | 2025 | Paradise Ultrasound Renal Denervation System |
| Bridgebio Pharma, INC. | $22.71 | 2025 | Attruby |
| Chiesi USA, INC. | $20.25 | 2023 | Cleviprex, Kengreal |
| Lexicon Pharmaceuticals, INC. | $19.92 | 2023 | Inpefa |
| Inspire Medical Systems, INC. | $15.42 | 2024 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.06 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $13.95 | 2019 | |
| Altathera Pharmaceuticals LLC | $13.93 | 2024 | Sotalol Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ejaz Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.